Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksBLISSGVS
resources
BLISSGVS

Bliss GVS Pharma Ltd.

NSE: BLISSGVS
BSE: 506197
Sector: Healthcare
Industry: Pharmaceuticals
483.50-21.5 (-4.25%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Bliss GVS Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Bliss GVS Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • AGM15 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find enclosed herewith the Voting Results alongwith the Scrutinizer Report for the 41st Annual General Meeting of the Company held on Wednesday, July 15, 2026.
  • AGM15 Jul 2026
    Proceedings Of 41St Annual General Meeting Of Bliss GVS Pharma Limited
    Please find attached herewith the proceedings of 41st Annual General Meeting of Bliss GVS Pharma Limited.
  • General15 Jul 2026
    Contact Details Of Kmps For Reporting Of Material Events To Stock Exchanges
    Please find enclosed herewith the details of KMPs for reporting Disclosure of Material Events to Stock Exchanges.
  • Allotment of ESOP / ESPS7 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    We like to inform you that the ESOP Allotment Committee of the Company at its meeting held today i.e. July 07, 2026 has approved the allotment of 1,87,750 equity shares of the face value ....
  • Change in Management3 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Enclosed herewith is the intimation regarding the Change in Management of the Company.
  • Outcome without intimation3 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, July 03, 2026
    Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that based on the recommendation ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20183 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please find enclosed herewith the Certificate under Regulation 74(5) of the SEBI (D&P) Regulations 2018, for the quarter ended June 30, 2026.
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Please find enclosed herewith the Intimation regarding the closure of the Trading Window for the quarter ended June 30, 2026.
  • Newspaper Publication24 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the Newspaper Advertisement published regarding Notice of 41st Annual General Meeting, E-voting and Book Closure Information.
  • Record Date23 Jun 2026
    Intimation Of Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')
    Please find enclosed herewith the intimation regarding the Fixation of the record date for the payment of the final dividend for the financial year ended March 31, 2026.
  • Book Closure23 Jun 2026
    Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')
    Please find enclosed herewith the intimation for the Book Closure for the purpose of 41st Annual General Meeting of the Company.
  • AGM23 Jun 2026
    Notice Of The 41St Annual General Meeting (''41St AGM'') Of Bliss GVS Pharma Limited
    Please find enclosed herewith the Notice of 41st AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Wednesday, July 15, 2026, at 11:00 A.M. (IST) through VC/OAVM. The ....
  • Reg. 34 (1) Annual Report23 Jun 2026
    Reg. 34 (1) Annual Report.
    Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), please find ....
  • General19 Jun 2026
    Communication To Shareholders - Intimation Of Tax Deduction On Dividend
    Please find enclosed herewith the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.
  • Newspaper Publication19 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the Newspaper publication regarding the 41st Annual General Meeting of the Company.
  • Allotment of ESOP / ESPS11 Jun 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. June 11, 2026 has approved the allotment of 267250 equity shares of face value Re.1/- each to ....
  • General9 Jun 2026
    Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
    Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited, the Manager to the Open Offer.
  • General9 Jun 2026
    Draft Letter of Offer
    SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma Ltd ("Target Company").
  • General2 Jun 2026
    Intimation Of WHO-GMP Compliance Of Manufacturing Facility
    Please find attached an intimation of WHO-GMP compliance of manufacturing facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20112 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs

Frequently Asked Questions

Where can I download the annual report of Bliss GVS Pharma Ltd.?
Annual reports of Bliss GVS Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Bliss GVS Pharma Ltd.?
Quarterly earnings results and presentations of Bliss GVS Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Bliss GVS Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Bliss GVS Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Bliss GVS Pharma Ltd.?
Investor presentations and annual day presentations of Bliss GVS Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Bliss GVS Pharma Ltd.?
Corporate announcements and regulatory filings of Bliss GVS Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Bliss GVS Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Bliss GVS Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Bliss GVS Pharma Ltd.?
The ISIN (International Securities Identification Number) of Bliss GVS Pharma Ltd. is INE416D01022. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Bliss GVS Pharma Ltd. listed?
Bliss GVS Pharma Ltd. is listed on NSE and BSE. The NSE symbol is BLISSGVS and the BSE code is -.
Where can I find the shareholding pattern of Bliss GVS Pharma Ltd.?
The quarterly shareholding pattern of Bliss GVS Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Bliss GVS Pharma Ltd. on Sharpely?
Share price data for Bliss GVS Pharma Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.